ELMD (Electromed) Moat Score: 4/10 (As of Jun. 30, 2026)


ELMD Electromed Inc ELMD
91 GF Score
Price $42.23
GF Value $25.16
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Electromed Moat Score?

Electromed ELMD +1.86% 91 Moat Score is 4 as of Jun. 30, 2026. GuruFocus rates ELMD with a GF Score™ of 91/100 and a GF Value™ of $25.16 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 846 Medical Devices & Instruments companies, Electromed ranks better than 83.33% on this metric.

Electromed has the Moat Score of 4, which implies that the company might have Narrow Moat - Discernible but modest moat.

Electromed has Narrow Moat: Electromed Inc has a modest moat due to its specialized medical devices, which create some customer switching costs and brand recognition. However, the market is competitive, and its scale is limited, preventing a stronger moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Electromed might have Narrow Moat - Discernible but modest moat.

Electromed  (AMEX:ELMD) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Electromed Moat Score Related Terms

ELMD vs CATX, MASS, CV: Moat Score Comparison

For the Medical Devices subindustry, Electromed's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Electromed Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Electromed's Moat Score distribution charts can be found below:

* The bar in red indicates where Electromed's Moat Score falls into.


ELMD
91GF Score
Electromed Inc ELMD
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 4 mean?
Electromed (ELMD) has a Moat Score of 4 as of Jun. 30, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Electromed ranks #141 out of 846 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Electromed's Moat Score too high?
Electromed's current Moat Score is 4. Based on the distribution chart, Electromed ranks #141 out of 846 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Electromed has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Electromed's Moat Score compare to CATX and MASS?
According to the Medical Devices & Instruments industry distribution chart, Electromed ranks #141 out of 846 companies for Moat Score. This places Electromed in the top 17% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Electromed's current Moat Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromed stock overvalued right now?
Based on GuruFocus' analysis, Electromed (ELMD) is currently considered Significantly Overvalued. The stock's GF Value™ is $25.16, compared to a current price of $42.23 — trading 67.8% above its estimated fair value. The current Moat Score is 4. Electromed's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Electromed (ELMD), the current Moat Score is 4 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Electromed (ELMD) Overvalued in 2026?

Based on GuruFocus' analysis, Electromed stock appears to be overvalued. The current stock price of $42.23 is trading 67.8% above its estimated GF Value™ of $25.16. GuruFocus considers Electromed to be Significantly Overvalued.

Key valuation signals for ELMD:

  • Moat Score: 4
  • GF Value™: $25.16 vs. price of $42.23 (67.8% above fair value)
  • GF Score™: 91/100 with 5 warning signs

No single metric tells the full story. See the ELMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Electromed Business Description

Address 500 Sixth Avenue NW, New Prague, MN, USA, 56071
Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.
91GF Score

Get the complete analysis for ELMD

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$42.23
Price
$25.16
GF Value